Clinical Trial Update: Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase IIa clinical trial evaluating Bardoxolone Methyl for renal function in diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Bardoxolone Methyl (bardoxolone methyl)

Snippet

Sponsor: Biogen | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED